Form 4: NewAmsterdam Pharma Co President Receives Stock Grant
Insider Transaction (Form 4)
Robert William Gunning, Vice President, Controller of NewAmsterdam Pharma Co N.V., reported multiple transactions in common stock on September 1, 2026.
Summary
- Grant/award: acquired 3,200 Ordinary Shares on September 1, 2026; holds 3,200 after (Direct).
- Grant/award: acquired 14,000 Option (right to buy) on September 1, 2026; holds 14,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert William Gunning — Officer (Vice President, Controller)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Ordinary Shares | 3,200 | — | — | 3,200 |
| 2026-09-01 | Grant/award | Option (right to buy) | 14,000 | — | — | 14,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (3,200 shares) |
| 2026-09-01 | Grant/award (14,000 shares) |
Keywords
insider transaction, Form 4, NAMS, NewAmsterdam Pharma Co N.V., neutral, Robert William Gunning
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.